Details for New Drug Application (NDA): 072696
✉ Email this page to a colleague
NDA 072696 describes NORTREL 1/35-28, which is a drug marketed by Barr Labs and is included in one NDA. It is available from one supplier. Additional details are available on the NORTREL 1/35-28 profile page.
The generic ingredient in NORTREL 1/35-28 is ethinyl estradiol; norethindrone. There is one drug master file entry for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
The generic ingredient in NORTREL 1/35-28 is ethinyl estradiol; norethindrone. There is one drug master file entry for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 072696
| Tradename: | NORTREL 1/35-28 |
| Applicant: | Barr Labs |
| Ingredient: | ethinyl estradiol; norethindrone |
| Patents: | 0 |
Suppliers and Packaging for NDA: 072696
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| NORTREL 1/35-28 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 072696 | ANDA | Teva Pharmaceuticals USA, Inc. | 0555-9010 | 0555-9010-58 | 6 POUCH in 1 CARTON (0555-9010-58) / 1 BLISTER PACK in 1 POUCH (0555-9010-79) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.035MG;1MG | ||||
| Approval Date: | Feb 28, 1992 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
